# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-25-089150
Filing Date
2025-09-11
Accepted
2025-09-10 18:15:35
Documents
42
Period of Report
2025-09-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2525814d1_8k.htm iXBRL | 8-K | 26671
2 | EXHIBIT 99.1 | tm2525814d1_ex99-1.htm | EX-99.1 | 45107
6 | GRAPHIC | tm2525814d1_ex99-1img001.jpg | GRAPHIC | 491193
7 | GRAPHIC | tm2525814d1_ex99-1img002.jpg | GRAPHIC | 620168
8 | GRAPHIC | tm2525814d1_ex99-1img003.jpg | GRAPHIC | 474919
9 | GRAPHIC | tm2525814d1_ex99-1img004.jpg | GRAPHIC | 284091
10 | GRAPHIC | tm2525814d1_ex99-1img005.jpg | GRAPHIC | 352596
11 | GRAPHIC | tm2525814d1_ex99-1img006.jpg | GRAPHIC | 296793
12 | GRAPHIC | tm2525814d1_ex99-1img007.jpg | GRAPHIC | 394202
13 | GRAPHIC | tm2525814d1_ex99-1img008.jpg | GRAPHIC | 270449
14 | GRAPHIC | tm2525814d1_ex99-1img009.jpg | GRAPHIC | 601433
15 | GRAPHIC | tm2525814d1_ex99-1img010.jpg | GRAPHIC | 317860
16 | GRAPHIC | tm2525814d1_ex99-1img011.jpg | GRAPHIC | 193108
17 | GRAPHIC | tm2525814d1_ex99-1img012.jpg | GRAPHIC | 161378
18 | GRAPHIC | tm2525814d1_ex99-1img013.jpg | GRAPHIC | 332346
19 | GRAPHIC | tm2525814d1_ex99-1img014.jpg | GRAPHIC | 239707
20 | GRAPHIC | tm2525814d1_ex99-1img015.jpg | GRAPHIC | 354451
21 | GRAPHIC | tm2525814d1_ex99-1img016.jpg | GRAPHIC | 383656
22 | GRAPHIC | tm2525814d1_ex99-1img017.jpg | GRAPHIC | 288818
23 | GRAPHIC | tm2525814d1_ex99-1img018.jpg | GRAPHIC | 129818
24 | GRAPHIC | tm2525814d1_ex99-1img019.jpg | GRAPHIC | 319942
25 | GRAPHIC | tm2525814d1_ex99-1img020.jpg | GRAPHIC | 236566
26 | GRAPHIC | tm2525814d1_ex99-1img021.jpg | GRAPHIC | 289569
27 | GRAPHIC | tm2525814d1_ex99-1img022.jpg | GRAPHIC | 307909
28 | GRAPHIC | tm2525814d1_ex99-1img023.jpg | GRAPHIC | 257289
29 | GRAPHIC | tm2525814d1_ex99-1img024.jpg | GRAPHIC | 239752
30 | GRAPHIC | tm2525814d1_ex99-1img025.jpg | GRAPHIC | 385294
31 | GRAPHIC | tm2525814d1_ex99-1img026.jpg | GRAPHIC | 368733
32 | GRAPHIC | tm2525814d1_ex99-1img027.jpg | GRAPHIC | 237347
33 | GRAPHIC | tm2525814d1_ex99-1img028.jpg | GRAPHIC | 501680
34 | GRAPHIC | tm2525814d1_ex99-1img029.jpg | GRAPHIC | 146566
| Complete submission text file | 0001104659-25-089150.txt |  | 13210106

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | armp-20250910.xsd | EX-101.SCH | 3026
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | armp-20250910_lab.xml | EX-101.LAB | 34239
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | armp-20250910_pre.xml | EX-101.PRE | 22366
44 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2525814d1_8k_htm.xml | XML | 3547

Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 251306801
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)